NMSIC Co-Investment Fund, L.P. 13D and 13G filings for Exagen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 4:15 pm Sale |
2025-03-25 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 1,758,958 9.830% |
-350,000 (-16.60%) |
Filing |
| 2025-01-29 7:00 pm Sale |
2024-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,108,958 11.960% |
-200,000 (-8.66%) |
Filing |
| 2024-01-22 4:15 pm Unchanged |
2023-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,308,958 13.550% |
0 (Unchanged) |
Filing |
| 2023-02-02 4:16 pm Unchanged |
2022-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,308,958 14.150% |
0 (Unchanged) |
Filing |
| 2022-02-10 4:15 pm Unchanged |
2021-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,308,958 14.280% |
0 (Unchanged) |
Filing |
| 2021-02-11 4:15 pm Sale |
2020-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,308,958 18.250% |
-125,000 (-5.14%) |
Filing |
| 2020-09-18 4:46 pm Purchase |
2020-09-01 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,433,958 19.260% |
2,433,958 (New Position) |
Filing |